Literature DB >> 8798448

Intracellular sites of prothyrotropin-releasing hormone processing.

I P Cruz1, E A Nillni.   

Abstract

Post-translational processing of proteins plays a key role in regulating their subcellular localization, enzymatic activity, and protein-protein interactions by such diverse mechanisms as phosphorylation, glycosylation, and proteolytic cleavage. The prothyrotropin-releasing hormone (pro-TRH) precursor (26 kDa) undergoes proteolytic cleavage at either of two sites, generating a 15/10-kDa or a 9.5/16.5-kDa N/C-terminal pair of intermediates. Using transfected AtT20 cells encoding a prepro-TRH cDNA, we have previously reported that this initial set of cleavages occurs prior to entry into the secretory granules (Nillni, E. A., Sevarino, K. A., and Jackson, I. M. D. (1993) Endocrinology 132, 1271-1277). In this study, we set out to identify the subcellular compartment where this initial cleavage takes place as well as to determine the sites of processing of the intermediates produced. Our strategy was to block the transport of pro-TRH or its intermediates from one subcellular compartment to the next and to assay for the accumulation of intermediates, presumably because their processing occurs in a post-blockade compartment. Radiolabeling experiments in AtT20 cells in the presence of the drug brefeldin A, which blocks transport from the endoplasmic reticulum to the Golgi complex, led to an accumulation of the 26-kDa precursor, suggesting a post-endoplasmic reticulum site of processing. When Golgi complex-to-secretory granule transport was blocked at 20 degrees C, the processing of the 26-kDa precursor was not affected, suggesting a Golgi complex site of processing. At this temperature, the 15-kDa N-terminal intermediate accumulated, suggesting a post-Golgi complex processing site, while the 16.5-kDa C-terminal intermediate was processed in the Golgi complex to produce a 5.4-kDa peptide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798448     DOI: 10.1074/jbc.271.37.22736

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Role of a pro-sequence in the secretory pathway of prothyrotropin-releasing hormone.

Authors:  Amparo Romero; Isin Cakir; Charles A Vaslet; Ronald C Stuart; Omar Lansari; Hector A Lucero; Eduardo A Nillni
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

Review 2.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

3.  Prothyrotropin-releasing hormone targets its processing products to different vesicles of the secretory pathway.

Authors:  Mario Perello; Ronald Stuart; Eduardo A Nillni
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

4.  Cell swelling induced secretion of TRH by posterior pituitary, hypothalamic paraventricular nucleus and pancreatic islets: effect of L-canavanine.

Authors:  M Najvirtová; L Baqi; J Kucerová; V Strbák
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

5.  Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Authors:  Ippolita Cantuti-Castelvetri; Ledia F Hernandez; Christine E Keller-McGandy; Lauren R Kett; Alex Landy; Zane R Hollingsworth; Esen Saka; Jill R Crittenden; Eduardo A Nillni; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

6.  Glucocorticoids modulate the biosynthesis and processing of prothyrotropin releasing-hormone (proTRH).

Authors:  T O Bruhn; S S Huang; C Vaslet; E A Nillni
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

7.  Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1.

Authors:  Samuel F Posner; Charles A Vaslet; Michelle Jurofcik; Alisson Lee; Nabil G Seidah; Eduardo A Nillni
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.